Basilea Pharmaceutica to get $1.25m license fee from Pfizer
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed.
Drugs
Medical
Pharma
Drugs
Health
Pharma
Roche to pay $42 million to Ascidian to make RNA exon editing drugs
Ascidian Therapeutics, a US-based biotechnology company announced a $42 million research pact with Swiss multinational Roche AG for developing gene editing therapies.
Health
Medical
Pharma
Cordis acquires medical device maker MedAlliance for $1.1 billion
HQ Team October 2, 2023: Cordis, a US-based medical device maker, has acquired Switzerland’s MedAlliance for up to $1.1 billion to expand its.
Climate
Health
Pharma
‘Dimming of sun’ to save Antarctic ice fraught with dangers
HQ Team August 14, 2023: The artificial cooling of climate through geo-engineering will not work without decarbonization and involves high risks, Swiss researchers.
Health
Medical
Pharma
Hobby with a personal meaning can fight loneliness, says study
HQ Team June 27, 2023: Any hobby with a personal meaning can ward off loneliness, a joint study found. “Loneliness are known to.
Drugs
Health
Pharma
Novartis to acquire Chinook Therapeutics in a $3.5 billion deal
HQ Team June 13, 2023: Swiss drugmaker, Novartis signed a $3.5 billion deal with Chinook Therapeutics to boost the US-based company’s last-stage experimental.
Climate
Health
Pharma
India’s L&T bags hydrocarbon order worth up to $305 million
HQ Team April 10, 2023: Larsen and Toubro, one of the world’s top construction companies, got an order worth up to INR 25.
Drugs
Pharma
Roche’s Alzheimer’s drug fails to meet primary target
Roche, a Swiss drugmaker, announced its Alzheimer's drug did not meet the primary goal of slowing the disease during two clinical trials